Dr Reddy's slips 7% following 8 USFDA observations for Duvvada plant
The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam.
The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam. https://ift.tt/2P0rckJ October 30, 2018 at 06:34PM
The stock slipped 7% to Rs 2,425 on the BSE after the pharmaceutical company said US health regulator issued eight observations after inspecting its formulations plant at Duvvada, Visakhapatnam. https://ift.tt/2P0rckJ October 30, 2018 at 06:34PM
Comments
Post a Comment